- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Hemostats market will register a 6.1% CAGR in terms of revenue, the global market size will reach US$ 2837.1 million by 2024, from US$ 2238.8 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Hemostats business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Hemostats market by product type, application, key manufacturers and key regions and countries.
This study considers the Hemostats value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Thrombin-Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Prehospital Treatment
Hospital Treatment
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Ethicon
Gelita Medical GmbH
Pfizer
C. R. Bard
The Medicines Company
Baxter International Inc.
Integra LifeSciences Corporation
Anika Therapeutics
B Braun Melsungen AG
Advanced Medical Solutions
BioCer Entwicklungs-GmbH.
Biom'Up SAS
Equimedical
Z-Medica, LLC
Marine Polymer Technologies
CryoLife
Vascular Solutions
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Hemostats consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Hemostats market by identifying its various subsegments.
Focuses on the key global Hemostats manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Hemostats with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Hemostats submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
Global Hemostats Market Growth 2019-2024
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hemostats Consumption 2014-2024
2.1.2 Hemostats Consumption CAGR by Region
2.2 Hemostats Segment by Type
2.2.1 Thrombin-Based Hemostats
2.2.2 Oxidized Regenerated Cellulose Based Hemostats
2.2.3 Combination Hemostats
2.2.4 Gelatin Based Hemostats
2.2.5 Collagen Based Hemostats
2.3 Hemostats Consumption by Type
2.3.1 Global Hemostats Consumption Market Share by Type (2014-2019)
2.3.2 Global Hemostats Revenue and Market Share by Type (2014-2019)
2.3.3 Global Hemostats Sale Price by Type (2014-2019)
2.4 Hemostats Segment by Application
2.4.1 Prehospital Treatment
2.4.2 Hospital Treatment
2.5 Hemostats Consumption by Application
2.5.1 Global Hemostats Consumption Market Share by Application (2014-2019)
2.5.2 Global Hemostats Value and Market Share by Application (2014-2019)
2.5.3 Global Hemostats Sale Price by Application (2014-2019)
3 Global Hemostats by Manufacturers
3.1 Global Hemostats Sales Market Share by Manufacturers
3.1.1 Global Hemostats Sales by Manufacturers (2017-2019)
3.1.2 Global Hemostats Sales Market Share by Manufacturers (2017-2019)
3.2 Global Hemostats Revenue Market Share by Manufacturers
3.2.1 Global Hemostats Revenue by Manufacturers (2017-2019)
3.2.2 Global Hemostats Revenue Market Share by Manufacturers (2017-2019)
3.3 Global Hemostats Sale Price by Manufacturers
3.4 Global Hemostats Manufacturing Base Distribution, Sales Area, Product Types by Manufacturers
3.4.1 Global Hemostats Manufacturing Base Distribution and Sales Area by Manufacturers
3.4.2 Players Hemostats Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Hemostats by Regions
4.1 Hemostats by Regions
4.1.1 Global Hemostats Consumption by Regions
4.1.2 Global Hemostats Value by Regions
4.2 Americas Hemostats Consumption Growth
4.3 APAC Hemostats Consumption Growth
4.4 Europe Hemostats Consumption Growth
4.5 Middle East & Africa Hemostats Consumption Growth
5 Americas
5.1 Americas Hemostats Consumption by Countries
5.1.1 Americas Hemostats Consumption by Countries (2014-2019)
5.1.2 Americas Hemostats Value by Countries (2014-2019)
5.2 Americas Hemostats Consumption by Type
5.3 Americas Hemostats Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Hemostats Consumption by Countries
6.1.1 APAC Hemostats Consumption by Countries (2014-2019)
6.1.2 APAC Hemostats Value by Countries (2014-2019)
6.2 APAC Hemostats Consumption by Type
6.3 APAC Hemostats Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Hemostats by Countries
7.1.1 Europe Hemostats Consumption by Countries (2014-2019)
7.1.2 Europe Hemostats Value by Countries (2014-2019)
7.2 Europe Hemostats Consumption by Type
7.3 Europe Hemostats Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Hemostats by Countries
8.1.1 Middle East & Africa Hemostats Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Hemostats Value by Countries (2014-2019)
8.2 Middle East & Africa Hemostats Consumption by Type
8.3 Middle East & Africa Hemostats Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Hemostats Distributors
10.3 Hemostats Customer
11 Global Hemostats Market Forecast
11.1 Global Hemostats Consumption Forecast (2019-2024)
11.2 Global Hemostats Forecast by Regions
11.2.1 Global Hemostats Forecast by Regions (2019-2024)
11.2.2 Global Hemostats Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Hemostats Forecast by Type
11.8 Global Hemostats Forecast by Application
12 Key Players Analysis
12.1 Ethicon
12.1.1 Company Details
12.1.2 Hemostats Product Offered
12.1.3 Ethicon Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Ethicon News
12.2 Gelita Medical GmbH
12.2.1 Company Details
12.2.2 Hemostats Product Offered
12.2.3 Gelita Medical GmbH Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Gelita Medical GmbH News
12.3 Pfizer
12.3.1 Company Details
12.3.2 Hemostats Product Offered
12.3.3 Pfizer Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Pfizer News
12.4 C. R. Bard
12.4.1 Company Details
12.4.2 Hemostats Product Offered
12.4.3 C. R. Bard Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 C. R. Bard News
12.5 The Medicines Company
12.5.1 Company Details
12.5.2 Hemostats Product Offered
12.5.3 The Medicines Company Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 The Medicines Company News
12.6 Baxter International Inc.
12.6.1 Company Details
12.6.2 Hemostats Product Offered
12.6.3 Baxter International Inc. Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Baxter International Inc. News
12.7 Integra LifeSciences Corporation
12.7.1 Company Details
12.7.2 Hemostats Product Offered
12.7.3 Integra LifeSciences Corporation Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Integra LifeSciences Corporation News
12.8 Anika Therapeutics
12.8.1 Company Details
12.8.2 Hemostats Product Offered
12.8.3 Anika Therapeutics Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Anika Therapeutics News
12.9 B Braun Melsungen AG
12.9.1 Company Details
12.9.2 Hemostats Product Offered
12.9.3 B Braun Melsungen AG Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 B Braun Melsungen AG News
12.10 Advanced Medical Solutions
12.10.1 Company Details
12.10.2 Hemostats Product Offered
12.10.3 Advanced Medical Solutions Hemostats Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Advanced Medical Solutions News
12.11 BioCer Entwicklungs-GmbH.
12.12 Biom'Up SAS
12.13 Equimedical
12.14 Z-Medica, LLC
12.15 Marine Polymer Technologies
12.16 CryoLife
12.17 Vascular Solutions
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Hemostats
Table Product Specifications of Hemostats
Figure Hemostats Report Years Considered
Figure Market Research Methodolo
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
